Papers by Pharm. Samson C Emelike
Texila Advanced Journal of Multidisciplinary Health Research, 2025
Public-Private Partnerships (PPPs) are increasingly recognized as vital mechanisms for improving ... more Public-Private Partnerships (PPPs) are increasingly recognized as vital mechanisms for improving healthcare supply chains in low-resource settings. These partnerships bring together the strengths of the public sector—such as policy oversight and equity goals—with the private sector’s efficiency, innovation, and logistical expertise. Healthcare supply chains in many low- and middle-income countries suffer from persistent challenges including inadequate infrastructure, fragmented delivery systems, funding shortfalls, and limited accountability. Through a structured literature review, this paper explores how PPPs can be leveraged to address these issues, with a focus on vaccine logistics and last-mile delivery. The paper discusses conceptual frameworks underpinning PPP models, identifies key operational strategies, and highlights examples from Nigeria, India, Kenya, Rwanda, and Senegal. These cases illustrate the impact of service contracts, digital tracking platforms, drone delivery systems, and informed push models in enhancing logistics performance. In addition to presenting the benefits of PPPs—including improved efficiency, accountability, and innovation—the paper also explores significant challenges such as regulatory gaps, donor dependency, and power asymmetries. Policy recommendations include the establishment of enabling legal frameworks, sustainable financing, stakeholder engagement, and robust monitoring systems. Overall, the findings support a strategic and evidence-based approach to PPPs as a pathway for strengthening healthcare logistics, particularly in environments constrained by resources and capacity limitations.
Research in Health Science, 2019
It is estimated that road traffic crashes account for the death of about 1.25 million people each... more It is estimated that road traffic crashes account for the death of about 1.25 million people each year, and it is the leading cause of death among youth between ages 15-29 years (WHO, 2016). Low and middle-income countries have about half of the world’s vehicle, and yet account for 90% of the world’s fatal accidents (WHO, 2016). Among the key risk factors for road accidents are speed, drink-driving, motorcycle helmets, seat-belts and child restraints, distracted driving (WHO, 2016). Tires maintenance or factors relating to the tire were not identified as risk factors by WHO. However, in Nigeria, it was estimated that between the years 2011 and 2015, tire bursts accounted for 7.8% of total causes of traffic crash in Nigeria (FRSC, 2016). Objective: This research aims to assess whether private vehicle drivers have better tire safety knowledge than commercial vehicle drivers in Nigeria. Methodology: The research employed a cross sectional study design on 454 motor vehicle drivers (comm...
TEXILA INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2017
HIV transmission can occur from mother to child during pregnancy, delivery and breastfeeding. The... more HIV transmission can occur from mother to child during pregnancy, delivery and breastfeeding. The use of Anti-Retroviral Drugs (ARD or ARVs) in Prevention of Mother to Child Transmission can significantly reduce this mode of transmission. The use of ARVs has been associated with occurrence of noxious effects known as Adverse Drug Reactions (ADRs). It is well known that women react more to drugs than men and some reasons proffered by some literature include hormonal differences in both sexes; but it is not known whether pregnancy can increase the chances of women reacting adversely to ARVs. Objective: The objective of the research is to investigate whether pregnancy can potentiate the occurrence of ADRs to ARVs. Methodology: The research employed a cross sectional Study Design on 150 HIV positive pregnant women, who were receiving ARVs at the time of study but who started ARVs before the current pregnancy. A simple Random Sampling Technique was employed in selecting the subjects. A wellstructured questionnaire was applied on the selected women to collect data. Data Analysis: The result was analyzed in a Mcnemar's test using Statistical Package for Social Sciences to determine the strength of association between the variables pregnancy and occurrence of ADRs for both the pregnant and the non-pregnant statuses of the same subjects. Result: The result showed that pregnancy does not contribute to the occurrence of Adverse Drug Reactions to Antiretroviral drugs among HIV pregnant women.
HIV transmission can occur from mother to child during pregnancy, delivery and breastfeeding. The... more HIV transmission can occur from mother to child during pregnancy, delivery and breastfeeding. The use of Anti-Retroviral Drugs (ARD or ARVs) in Prevention of Mother to Child Transmission can significantly reduce this mode of transmission. The use of ARVs has been associated with occurrence of noxious effects known as Adverse Drug Reactions (ADRs). It is well known that women react more to drugs than men and some reasons proffered by some literature include hormonal differences in both sexes; but it is not known whether pregnancy can increase the chances of women reacting adversely to ARVs. Objective: The objective of the research is to investigate whether pregnancy can potentiate the occurrence of ADRs to ARVs. Methodology: The research employed a cross sectional Study Design on 150 HIV positive pregnant women, who were receiving ARVs at the time of study but who started ARVs before the current pregnancy. A simple Random Sampling Technique was employed in selecting the subjects. A well-structured questionnaire was applied on the selected women to collect data. Data Analysis: The result was analyzed in a Mcnemar's test using Statistical Package for Social Sciences to determine the strength of association between the variables pregnancy and occurrence of ADRs for both the pregnant and the non-pregnant statuses of the same subjects. Result: The result showed that pregnancy does not contribute to the occurrence of Adverse Drug Reactions to Antiretroviral drugs among HIV pregnant women.
Uploads
Papers by Pharm. Samson C Emelike